Get started
Author

Anne Etienne

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
2012 · Norbert Vey, Jean-Henri Bourhis, et al. · Blood · 289
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
2007 · Anne Etienne, Benjamin Esterni, et al. · Cancer · 171
PDF
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
2008 · J.-V. Malfuson, A. Etienne, et al. · Haematologica · 140
PDF
Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
2012 · Julie Gertner-Dardenne, Remy Castellano, et al. · The Journal of Immunology · 134
Tumour lysis syndrome and acute kidney injury in high‐risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en R éanimation Respiratoire et O nco‐ H ématologique
2013 · Michael Darmon, François Vincent, et al. · British Journal of Haematology · 117
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT
2012 · R Devillier, R Crocchiolo, et al. · Bone Marrow Transplantation · 71
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
2012 · Raynier Devillier, Roberto Crocchiolo, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 52
Veillonella montpellierensisEndocarditis
2005 · Clarisse Rovery, Anne Etienne, et al. · Emerging infectious diseases · 45
PDF
Critically ill cancer patients in the intensive care unit: short‐term outcome and 1‐year mortality
2011 · D. MOKART, A. ETIENNE, et al. · Acta Anaesthesiologica Scandinavica · 36
Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes
2007 · Anne Etienne, Nadine Carbuccia, et al. · Cancer Genetics and Cytogenetics · 33
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor
2013 · Raynier Devillier, Sabine Fürst, et al. · American Journal of Hematology · 28
Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient
2008 · A. Etienne, A. Datry, et al. · Mycoses · 28
Comparison of 60 or 90 mg/m2 of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics
2014 · Raynier Devillier, Sarah Bertoli, et al. · American Journal of Hematology · 26
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study
2014 · P. Chevallier, F. Huguet, et al. · Haematologica · 25
PDF
t(5;12)(q23–31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera
2006 · A Murati, J Adélaïde, et al. · Leukemia · 23
Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder
2007 · Anne Etienne, Véronique Gelsi-Boyer, et al. · Cancer Genetics and Cytogenetics · 22
Improved outcome of patients with low‐ and intermediate‐risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: Results of a retrospective comparative study
2010 · Thomas Prebet, Anne Etienne, et al. · Cancer · 20
Prognostic significance of myelodysplasia‐related changes according to the WHO classification among ELN ‐intermediate‐risk AML patients
2014 · Raynier Devillier, Véronique Gelsi‐Boyer, et al. · American Journal of Hematology · 19
PDF
Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: Efficacy and safety of anti‐CD20 (rituximab) treatment
2004 · Anne Etienne, Stéphane Gayet, et al. · American Journal of Hematology · 18
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study
2012 · Patrice Chevallier, Nelly Robillard, et al. · Blood · 16
Poor Outcome with Nonmyeloablative Conditioning Regimen before Cord Blood Transplantation for Patients with High-Risk Acute Myeloid Leukemia Compared with Matched Related or Unrelated Donor Transplantation
2014 · Raynier Devillier, Samia Harbi, et al. · Transplantation and Cellular Therapy · 11
Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients
2018 · Colombe Saillard, Elodie Elkaim, et al. · Leukemia Research · 9
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction
2012 · Thomas Prébet, Estelle Jean, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia
2013 · Colombe Saillard, Anne Etienne, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Repeated Dosing Of Anti-KIR (IPH2101) As Maintenance Therapy In Ederly Patients With Acute Myeloid Leukemia
2013 · Norbert Vey, Jean-Henri Bourhis, et al. · Blood · 6
Works count: 52
Citation count: 1,371
H-index: 18
I10-index: 21
Year
Topic
Type